Table 1 Baseline Characteristics
Characteristics | Patients (n = 22) |
|---|---|
Gender (male) % | 12 (55) |
Age (years) Median (range) | 15 (10–21) |
Ethnicity (%) | |
Caucasian | 14 (63.6) |
African American | 3 (13.6) |
Hispanic | 3 (13.6) |
Other | 2 (9.1) |
Baseline Stimulation | |
VNS (%) | 10 (45.5) |
Sham (%) | 12 (55.5) |
Diagnosis | |
Crohn Disease (%) | 10 (45.5) |
Ulcerative Colitis (%) | 12 (55.5) |
CD Paris Classification (n) | |
L1 | 3 |
L2 | 6 |
L3 | 1 |
UC Paris Classification (n) | |
E1 | 1 |
E2 | 1 |
E3 | 3 |
E4 | 7 |
Baseline wPCDAI, Median (range) | 22.5 (0–57.5) |
Baseline PUCAI Median (range) | 10 (0–45) |
Concomitant IBD Medications (n) | |
None | 4 |
5-ASA | 8 |
Methotrexate (monotherapy) | 4 |
Adalimumaba | 3 |
Vedolizumab | 3 |